A session held virtually at the American College of Obstetrics and Gynecology’s (ACOG) Annual Clinical and Scientific Meeting, which started on April 30, focused on the new ASCCP guidelines and highlighted the importance of identifying risk for management of abnormal screenings.
Diversity, equity, and inclusion (DEI) was a key theme that helped to kick off the annual meeting, which was held virtually. During the Hale Lecture: Diversity and Equity in Obstetrics and Gynecology – The Patient and the Provider – Care Delivery to Employment, several ob/gyns provided their own perspectives, including sharing data on diversity in the specialty now and its implications for the future pipeline.
Eva Chalas, MD, kicked off the Annual Clinical and Scientific Meeting as ACOG’s 71st president. Her keynote speech focused on her presidential initiative of personalized care. The goal was to provide guidance and tools to assist ob/gyns in enhancing access to comprehensive preventive care.
In a lightning round for the 2021 ACOG Annual Clinical and Scientific Meeting, David B. Nelson, MD, presented ‘Acute Fatty Liver of Pregnancy.’ Nelson is Chief of Obstetrics and Maternal Medical Director at Parkland Hospital. He is also Assistant Professor of Maternal-Fetal Medicine for the Department of Obstetrics and Gynecology at the University of Texas Southwestern Medical Center.
A panel discussion at the 2021 American College of Obstetrics and Gynecology’s (ACOG) Annual and Scientific Meeting, being held virtually April 30-May 2, offers insight into how the COVID-19 pandemic has changed telehealth in ob/gyn.
Contemporary OB/GYN®’s Associate Editor, Lindsey Carr, sat down with board member Yalda Afshar, MD, Ph.D., to discuss mental health and burnout in ob/gyn.
President Biden signed legislation extending the moratorium on a 2 percent Medicare cut.
Round two of the program will provide $249 million to support physicians by providing reimbursement of services necessary for telehealth.
This indication is approved under accelerated approval based on tumor response rate and durability of response.
A study offers much needed information on the rate of infant mortality in infants who have prenatal exposure to opioids.
Early and routine contraceptive counseling for all women of reproductive age with cardiovascular disease or cardiovascular risk factors is an essential component of comprehensive cardiovascular care, according to evidence-based recommendations of contraceptive options published in the Journal of the American College of Cardiology (JACC).
Women with diabetes are slightly less likely to use contraception after their diabetes diagnosis, according to a retrospective cohort study in the journal Primary Care Diabetes.
Contemporary OB/GYN®’s Associate Editor, Lindsey Carr, sat down with board member Yalda Afshar, MD, PhD, to discuss mental health and burnout in ob/gyn.
A look at what's coming to Contemporary OB/GYN® this week.
“Researching how obesity impacts menstrual blood loss is important to improve the ways we prevent and treat the debilitating symptom of heavy menstrual bleeding,” said Jacqueline Maybin, MBChB, PhD, senior research fellow and honorary consultant gynecologist at the MRC Centre for Reproductive Health at the University of Edinburgh.
It was a very busy week for the Contemporary OB/GYN team.
Nextstellis (drospirenone; estetrol) now is approved as a combined oral contraceptive for birth control.
New guidance from the American College of Obstetrics and Gynecologists (ACOG) calls on ob/gyns to recognize the prevalence of trauma and its impact on patients and health care teams and outlines the importance of trauma-informed approaches to delivery of care.
Transcervical fibroid ablation (TFA) to treat symptomatic uterine fibroids (UFs) is effective for a wide range of fibroid types and sizes, according to preliminary results of the first 160 women treated in the Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE registry).
Expanding coverage for noninvasive prenatal testing (NIPT) through a performance-based, risk-sharing agreement (PBRSA) resulted in a significant increase in NIPT use, a significant decrease in conventional prenatal screening methods, and a negligible increase in per member per month (PMPM) cost at Harvard Pilgrim Health Care (HPHC) in New England.
The CDC and FDA will further investigate the reports of blood clots following administration of the vaccine.
A literature review has found that the prevalence thresholds of various screening tests used in ob/gyn health care settings are significantly higher than the estimated disease prevalence.
Overactive bladder affects a significant portion of the overall population and has substantial impact on daily activities and quality of life.
This case illustrates how a clear explanation and empathy for the patient’s concerns may have avoided litigation altogether.
A higher risk of adult-onset heart failure was found in this Swedish study that investigated its association with singleton live births before 37 weeks gestation.
A team of investigators has found that women with Down Syndrome received gynecologic care at lower-than-recommended rates and at substantially lower rates than other forms of health care. The investigators have called for efforts to improve gynecologic care for this vulnerable population.
What to look for this week on Contemporary OB/GYN®
Curbside Consults delivers expert perspectives from physicians outside of the OB/GYN specialty to provide insight into various health issues affecting pregnant women. This new section is the brainchild of Editorial Advisory Board member Christine Isaacs, MD.
It was a very busy week for the Contemporary OB/GYN® team.
Peer-reviewed
Treating COVID-19 in pregnant patients brings extra challenges, risks.
